Active Ingredient(s): Hyaluronidase
FDA Approved: * October 26, 2004
Pharm Company: * AMPHASTAR PHARM
Category: Medical Device

Hyaluronidases are a family of enzymes that catalyse the degradation of hyaluronic acid (HA). Karl Meyer classified these enzymes in 1971, into three distinct groups, a scheme based on the enzyme reaction products.[1] The three main types of hyaluronidases are two classes of eukaryotic endoglycosidase hydrolases and a prokaryotic lyase-type of glycosidase.[2] In humans, there are five functional hyaluronidases: HYAL1, HYAL2, HYAL3, HYAL4 and HYAL5 (also known a... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Amphadase 150 [usp'u]/Ml Subcutaneous Injection
NDC: 0548-9090
Amphastar Pharmaceuticals, Inc.

Related Brands

Drugs with the same active ingredients